Some 300 jobs are staying in mid-Michigan as Emergent Biosolutions moves forward with the expansion of Lansing's Bioport Corporation.
Bioport is building a new high tech vaccine production facility. This year the company secured its second five million dose contract, with the United States Government, to make the anthrax vaccine. Bioport is the only licensed manufacturer of the anthrax vaccine.
Construction of the 50,000 square foot facility began in February; it should be finished sometime in 2007. Vaccine production is expected to begin in 2008.